1372
M. Makabe et al.
PAPER
N-(E)-{(3,3-Bis[(benzyloxy)methyl]-6-(trimethylsilyl)hex-5-yn-
1-ylidene}-1-phenylmethanamine (3a)
silica gel (hexane–EtOAc, 15:1) to give 5a as a colorless oil (100.7
mg, 64%).
IR (neat): 3029, 2956, 2859, 2360, 2172, 1663, 1452, 1364, 1249,
IR (neat): 3027, 2951, 2854, 1496, 1453, 1249, 1098 cm–1.
1098, 1028 cm–1.
1H NMR (400 MHz, CDCl3): d = 0.23 (s, 9 H), 1.85 (dd, J = 5.2,
13.6 Hz, 1 H), 1.93 (dd, J = 7.2, 13.6 Hz, 1 H), 2.12 (br s, 1 H), 2.37
(d, J = 16.0 Hz, 1 H), 2.60 (d, J = 16.0 Hz, 1 H), 3.21 (d, J = 8.8 Hz,
1 H), 3.31 (d, J = 8.8 Hz, 1 H), 3.52 (d, J = 8.4 Hz, 1 H), 2.58 (d,
J = 8.4 Hz, 1 H), 3.65 (dd, J = 12.0, 19.0 Hz, 2 H), 3.66–3.68 (m, 1
H), 4.46 (dd, J = 12.0, 18.8 Hz, 2 H), 4.52 (dd, J = 12.4, 17.2 Hz, 2
H), 7.21–7.33 (m, 15 H).
13C NMR (100 MHz, CDCl3): d = 1.0 (CH3), 37.0 (CH2), 40.2
(CH2), 48.0 (CH2), 51.2 (CH2), 69.0 (CH), 73.0 (CH2), 73.2
(CH2 × 2), 74.1 (CH2), 104.0 (C), 126.8 (CH), 127.3 (CH × 4),
128.2 (CH × 3), 128.5 (CH), 138.5 (C), 138.6 (C), 140.1 (C), 162.5
(C).
1H NMR (400 MHz, CDCl3): d = 0.11 (s, 9 H), 2.45 (s, 2 H), 2.50
(d, J = 5.2 Hz, 2 H), 3.47 (s, 4 H), 4.46 (s, 4 H), 4.49 (s, 2 H), 7.20–
7.36 (m, 15 H), 7.86 (t, J = 5.2 Hz, 1 H).
13C NMR (100 MHz, CDCl3): d = 0.4 (CH3), 24.7 (CH2), 39.8
(CH2), 42.5 (C), 65.2 (CH2), 72.6 (CH2 × 2), 73.3 (CH2 × 2), 87.1
(C), 103.6 (C), 126.6 (CH2), 127.2 (CH2 × 2), 127.2 (CH2 × 2),
127.7 (CH2), 128.0 (CH2 × 2), 128.2 (CH2), 138.2 (C × 2), 139.1
(C), 163.7 (CH).
LRMS (EI): m/z 497 [M+], 482, 406, 376, 91.
HRMS (EI): m/z [M+] calcd for C32H39NO2Si: 497.2750; found:
497.2731.
LRMS (EI): m/z 625 [M+], 610 [M+ – Me], 534 [M+ – Bn], 498 [M+
(E)-N-Benzyl-4,4-bis[(benzyloxy)methyl]-2-[(trimethylsilyl)-
methylene]cyclopentanamine (4a)
– I], 91 [Bn].
HRMS (EI): m/z [M+] calcd for C32H40INO2Si: 625.1873; found:
625.1872.
Crude product 4a, which was prepared from 3a (124.4 mg, 0.25
mmol), Cp2ZrCl2 (95 mg, 0.325 mmol), and BuLi (1.49 M, 0.43
mL, 0.65 mmol) was purified by column chromatography on silica
gel (hexane–EtOAc, 10:1) to give 4a as a colorless oil (114.2 mg,
91%).
3,3-Bis[(benzyloxy)methyl]hept-5-ynal (1b)
IR (neat): 3030, 2918, 2858, 1717, 1454, 1364, 1096 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.74 (t, J = 2.4 Hz, 3 H), 2.40 (dd,
J = 2.4, 5.2 Hz, 2 H), 2.49 (d, J = 2.8 Hz, 2 H), 3.47–3.53 (m, 4 H),
4.47 (s, 4 H), 7.23–7.34 (m, 10 H), 9.80 (t, J = 2.8 Hz, 1 H).
13C NMR (100 MHz, CDCl3): d = 3.7 (CH3), 23.8 (CH2), 42.8 (C),
47.1 (CH2), 72.4 (CH2 × 2), 73.3 (CH2 × 2), 74.8 (C), 78.5 (C),
127.2 (CH × 2), 127.3 (CH × 2), 128.1 (CH × 2), 137.9 (C × 2),
201.3 (CH).
IR (neat): 3028, 2951, 2853, 1453, 1249, 1099, 838, 734 cm–1.
1H NMR (400 MHz, CDCl3): d = 0.09 (s, 9 H), 1.35 (dd, J = 8.8,
12.8 Hz, 1 H), 1.52 (br s, 1 H), 2.08 (dd, J = 7.6, 13.2 Hz, 1 H), 2.32
(dd, J = 1.6, 16.6 Hz, 1 H), 2.40 (td, J = 1.6, 16.8 Hz, 1 H), 3.33 (s,
2 H), 3.42 (s, 2 H), 3.48 (t, J = 8.0 Hz, 1 H), 3.71 (d, J = 12.8 Hz, 1
H), 3.80 (d, J = 12.8 Hz, 1 H), 4.48 (dd, J = 12.4, 16.0 Hz, 2 H), 4.51
(s, 2 H), 5.46 (q, J = 1.6 Hz, 1 H), 7.20–7.34 (m, 15 H).
LRMS (EI): m/z 350 [M+], 306 [M+ – CH2CHO – H], 259 [M+ –
13C NMR (100 MHz, CDCl3): d = –0.17 (CH3), 37.5 (CH2), 38.4
(CH2), 45.1 (C), 51.8 (CH2), 62.4 (CH), 73.2 (CH2 × 2), 73.3
(CH2 × 2), 119.5 (CH), 126.7 (CH2), 127.3 (CH2 × 2), 127.4 (CH2),
128.0 (CH2), 128.2 (CH2 × 2), 138.6 (C × 2), 140.5 (C), 161.6 (C).
Bn], 229 [M+ – CH2OBn], 107 [OBn], 91 [Bn].
HRMS (EI): m/z [M+] calcd for C23H26O3: 350.1882; found:
350.1885.
LRMS (EI): m/z 499 [M+], 426 [M+ – TMS], 408 [M+ – Bn], 378
(2E)-N-Benzyl-4,4-bis[(benzyloxy)methyl]-2-ethylidenecyclo-
pentanamine (4b)
[M+ – CH2OBn], 106 [BnNH], 91 [Bn], 73 [TMS].
HRMS (EI): m/z [M+] calcd for C32H41NO2Si: 499.2906; found:
IR (neat): 3061, 3028, 2854, 1453, 1363, 1098 cm–1.
499.2920.
1H NMR (400 MHz, CDCl3): d = 1.41 (dd, J = 7.2, 13.0 Hz, 1 H),
1.59 (dd, J = 1.6, 6.8 Hz, 3 H), 1.64 (br s, 1 H), 2.06 (dd, J = 7.2,
13.2 Hz, 1 H), 2.26 (dd, J = 16.8, 18.4 Hz, 2 H), 3.32 (dd, J = 8.8,
12.4 Hz, 2 H), 3.46–3.51 (m, 1 H), 3.48 (dd, J = 8.8, 10.4 Hz, 2 H),
3.71 (d, J = 13.2 Hz, 1 H), 3.79 (d, J = 13.2 Hz, 1 H), 4.49 (s, 2 H),
4.52 (s, 2 H), 5.40–5.43 (m, 1 H), 7.21–7.33 (m, 15 H).
13C NMR (100 MHz, CDCl3): d = 14.5 (CH3), 34.2 (CH2), 39.2
(CH2), 45.5 (C), 51.5 (CH2), 60.7 (CH), 73.1 (CH2), 73.2 (CH2),
73.7 (CH2), 75.0 (CH2), 117.1 (C), 126.7 (CH), 127.2 (CH × 2),
127.3 (CH), 127.4 (CH), 128.0 (CH), 128.2 (CH × 3), 138.6 (C),
138.7 (C), 140.4 (C), 143.7 (C).
(E)-N-Benzyl-4,4-bis[(benzyloxy)methyl]-2-[(trimethylsilyl)-
methylene]cyclopentanamine-d1 (4a-D)
IR (neat): 3028, 2951, 2853, 1453, 1249, 1099, 838, 734 cm–1.
1H NMR (400 MHz, CDCl3): d = 0.09 (s, 9 H), 1.35 (dd, J = 8.0,
13.2 Hz, 1 H), 1.68 (br s, 1 H), 2.08 (dd, J = 8.0, 13.0 Hz, 1 H), 2.32
(d, J = 16.8 Hz, 1 H), 2.30 (td, J = 1.6, 16.8 Hz, 1 H), 3.33 (s, 2 H),
3.42 (s, 2 H), 3.48 (t, J = 8.4 Hz, 1 H), 3.72 (d, J = 8.4 Hz, 1 H), 3.81
(d, J = 13.2 Hz, 1 H), 4.49 (dd, J = 12.4, 15.8 Hz, 2 H), 4.50 (s, 2
H), 7.20–7.34 (m, 15 H).
LRMS (EI): m/z 500 [M+], 427 [M+ – TMS], 409 [M+ – Bn], 393
LRMS (EI): m/z 441 [M+], 413 [M+ – C2H4], 350 [M+ – Bn], 320
[M+ – OBn], 379 [M+ – CH2OBn], 106 [BnNH], 91 [Bn], 73 [TMS].
[M+ – CH2OBn], 91 [Bn].
HRMS (EI): m/z [M+] calcd for C32H40DNO2Si: 500.2968; found:
500.2967.
HRMS (EI): m/z [M+] calcd for C30H35NO2: 441.2668; found:
441.2658.
(2Z)-N-Benzyl-4,4-bis[(benzyloxy)methyl]-2-[iodo(trimethylsi-
lyl)methylene]cyclopentanamine (5a)
3,3-Bis[(benzyloxy)methyl]-7-{[t-butyl(dimethyl)silyl]oxy}-
hept-5-ynal (1c)
To a solution of azazirconacyclopentene 7a, which was prepared
from 3a (124.4 mg, 0.25 mmol), Cp2ZrCl2 (95 mg, 0.325 mmol),
and BuLi (1.49 M, 0.43 mL, 0.65 mmol) in THF (2 mL) was added
I2 (76 mg, 0.3 mmol) in THF (0.5 mL) at –78 °C. The solution was
stirred at r.t. for 2 h. To this solution was added a 20% solution of
Na2S2O3 and the aqueous layer was extracted with EtOAc. The or-
ganic layer was washed with brine, dried over Na2SO4 and concen-
trated. The residue was purified by column chromatography on
IR (neat): 3035, 2928, 2857, 1718, 1454, 1364, 1255, 1079 cm–1.
1H NMR (400 MHz, CDCl3): d = 0.10 (s, 6 H), 0.90 (s, 9 H), 2.50
(s, 2 H), 2.51 (s, 2 H), 3.48–3.54 (m, 4 H), 4.26 (br s, 2 H), 4.47 (s,
4 H), 7.26–7.34 (m, 10 H), 9.79 (t, J = 2.4 Hz, 1 H).
13C NMR (100 MHz, CDCl3): d = -5.1 (CH3), 18.25 (C), 23.5 (CH2),
25.7 (CH3), 42.4 (C), 46.8 (CH2), 51.7 (CH2), 72.1 (CH2 × 2), 73.1
Synthesis 2004, No. 9, 1369–1374 © Thieme Stuttgart · New York